Lv41
660 积分 2023-10-12 加入
Interleukin-33 in health and disease
25天前
已完结
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
29天前
已完结
Biologics in Asthma: Potential to Achieve Clinical Remission
1个月前
已关闭
Biologics in Asthma: Emerging Biologics
1个月前
已关闭
Biologics in Asthma: Role of Biomarkers
1个月前
已关闭
Non-T2 asthma
1个月前
已完结
Asthma Biologics
1个月前
已关闭
Atopic Dermatitis (eczema) Guidelines 2023: Highlights
1个月前
已完结
Type 2 severe asthma: pathophysiology and treatment with biologics
1个月前
已完结
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis
1个月前
已完结
皖公网安备34019202002308
